UniProt ID | UB2V2_HUMAN | |
---|---|---|
UniProt AC | Q15819 | |
Protein Name | Ubiquitin-conjugating enzyme E2 variant 2 | |
Gene Name | UBE2V2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 145 | |
Subcellular Localization | ||
Protein Description | Has no ubiquitin ligase activity on its own. The UBE2V2/UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through 'Lys-63'. This type of poly-ubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage.. | |
Protein Sequence | MAVSTGVKVPRNFRLLEELEEGQKGVGDGTVSWGLEDDEDMTLTRWTGMIIGPPRTNYENRIYSLKVECGPKYPEAPPSVRFVTKINMNGINNSSGMVDARSIPVLAKWQNSYSIKVVLQELRRLMMSKENMKLPQPPEGQTYNN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAVSTGVKV ------CCCCCCCCC | 12.17 | 22814378 | |
4 | Phosphorylation | ----MAVSTGVKVPR ----CCCCCCCCCCC | 15.20 | 24719451 | |
5 | Phosphorylation | ---MAVSTGVKVPRN ---CCCCCCCCCCCC | 39.12 | 24719451 | |
8 | Ubiquitination | MAVSTGVKVPRNFRL CCCCCCCCCCCCCHH | 48.11 | - | |
8 | Acetylation | MAVSTGVKVPRNFRL CCCCCCCCCCCCCHH | 48.11 | 25953088 | |
41 | Sulfoxidation | GLEDDEDMTLTRWTG CCCCCCCCEEEEEEE | 2.88 | 30846556 | |
49 | Sulfoxidation | TLTRWTGMIIGPPRT EEEEEEEEEECCCCC | 1.25 | 30846556 | |
56 | Phosphorylation | MIIGPPRTNYENRIY EEECCCCCCCCCCEE | 48.18 | 21406692 | |
58 | Phosphorylation | IGPPRTNYENRIYSL ECCCCCCCCCCEEEE | 17.61 | 21406692 | |
61 | Methylation | PRTNYENRIYSLKVE CCCCCCCCEEEEEEE | 19.79 | 115919393 | |
63 | Phosphorylation | TNYENRIYSLKVECG CCCCCCEEEEEEECC | 12.52 | 21406692 | |
64 | Phosphorylation | NYENRIYSLKVECGP CCCCCEEEEEEECCC | 21.24 | 24719451 | |
66 | Acetylation | ENRIYSLKVECGPKY CCCEEEEEEECCCCC | 30.01 | 25953088 | |
66 | Ubiquitination | ENRIYSLKVECGPKY CCCEEEEEEECCCCC | 30.01 | 21890473 | |
69 | Glutathionylation | IYSLKVECGPKYPEA EEEEEEECCCCCCCC | 14.67 | 22555962 | |
72 | Acetylation | LKVECGPKYPEAPPS EEEECCCCCCCCCCC | 59.74 | 23749302 | |
72 | Ubiquitination | LKVECGPKYPEAPPS EEEECCCCCCCCCCC | 59.74 | 21906983 | |
79 | Phosphorylation | KYPEAPPSVRFVTKI CCCCCCCCEEEEEEE | 25.51 | 27251275 | |
84 | Phosphorylation | PPSVRFVTKINMNGI CCCEEEEEEEECCCC | 24.40 | 28674151 | |
88 | Sulfoxidation | RFVTKINMNGINNSS EEEEEEECCCCCCCC | 5.75 | 21406390 | |
94 | Phosphorylation | NMNGINNSSGMVDAR ECCCCCCCCCCCCCC | 24.63 | 20068231 | |
95 | Phosphorylation | MNGINNSSGMVDARS CCCCCCCCCCCCCCH | 32.79 | 20068231 | |
101 | Methylation | SSGMVDARSIPVLAK CCCCCCCCHHHEEEE | 30.56 | 115919385 | |
102 | Phosphorylation | SGMVDARSIPVLAKW CCCCCCCHHHEEEEC | 32.72 | 27251275 | |
108 | Acetylation | RSIPVLAKWQNSYSI CHHHEEEECCCCCCH | 45.19 | 25953088 | |
108 | Ubiquitination | RSIPVLAKWQNSYSI CHHHEEEECCCCCCH | 45.19 | 21890473 | |
112 | Phosphorylation | VLAKWQNSYSIKVVL EEEECCCCCCHHHHH | 12.73 | 26091039 | |
113 | Phosphorylation | LAKWQNSYSIKVVLQ EEECCCCCCHHHHHH | 23.20 | 20049867 | |
114 | Phosphorylation | AKWQNSYSIKVVLQE EECCCCCCHHHHHHH | 18.76 | 24719451 | |
123 | Methylation | KVVLQELRRLMMSKE HHHHHHHHHHHCCHH | 29.00 | - | |
129 | Ubiquitination | LRRLMMSKENMKLPQ HHHHHCCHHHCCCCC | 34.90 | - | |
133 | Acetylation | MMSKENMKLPQPPEG HCCHHHCCCCCCCCC | 69.47 | 25953088 | |
133 | Ubiquitination | MMSKENMKLPQPPEG HCCHHHCCCCCCCCC | 69.47 | - | |
143 | Phosphorylation | QPPEGQTYNN----- CCCCCCCCCC----- | 12.57 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UB2V2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UB2V2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UB2V2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-72, AND MASS SPECTROMETRY. |